Steinberg Diagnostic Medical Imaging Installs First Toshiba Medical Vantage Galan 3T

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Designed for Patient Comfort; Makes Fast 3T MR Exams a Reality

-Patients in Las Vegas, Nev., now have access to cutting-edge 3T MR exams at Steinberg Diagnostic Medical Imaging (SDMI) with the installation of the Vantage GalanTM 3T from Toshiba Medical, a Canon Group company. SDMI, one of the largest outpatient imaging centers in the United States and a 29-year research partner with Toshiba Medical, is the first healthcare provider in the country to install the Vantage Galan 3T. SDMI is leveraging the system’s patient-friendly features and streamlined operability to bring the most advanced MR technology to physicians for the betterment of their patients.

“We want to be the most cutting-edge outpatient radiology practice in the United States, and as the first facility to install Toshiba Medical’s Vantage Galan 3T, we are confident in our ability to quickly provide more comfortable, fast and accurate exams,” said Dr. Mark Winkler, professor of health sciences at the University of Nevada, Las Vegas and founding partner of SDMI. “SDMI strives to be the best in research and patient care, and the Vantage Galan 3T helps us meet both needs.”

SDMI is using the Vantage Galan 3T for a variety of imaging procedures, including advanced brain imaging, dementia, spine and joint diagnostics, as well as staging for transplantation patients. This premium MR solution offers a comprehensive range of clinical applications including neuro, musculoskeletal, abdominal, cardiovascular, breast and prostate. The Vantage Galan 3T is designed to increase signal-to-noise ratio (SNR) by up to 20 percent, allowing for faster sampling and higher resolution images thanks to PURERF and Saturn technologies.

SDMI will benefit from Toshiba Medical’s four generations of unique, non-contrast MRA sequences that minimize risk to patients while producing exceptional images. The Vantage Galan 3T also makes scanning even more quiet with Pianissimo™ Zen technology that reduces sound during acquisition by 99 percent.*

“We are committed to providing our customers with the very best tools in diagnostic imaging so they can put their patients at ease,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Toshiba America Medical Systems, Inc. “While 3T has often been limited to research settings, the Vantage Galan 3T allows healthcare providers to offer routine, high-quality MR imaging to their patients. With our new Vantage Galan 3T, clinicians at SDMI can simplify complex MR exams and offer patients a quiet and more comfortable experience.”

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles